<div class="modal-header">
  <button type="button" class="close"
    data-dismiss="modal" aria-hidden="true">&times;</button>
  <h4 class="modal-title" id="myModalLabel">李志杰</h4>
</div>

<div class="modal-body">
  <div class="row">

    <!-- PICTURE GOES HERE -->
    <div class = "col-md-4">
      <img class="media-object imageSizeDetailed img-rounded"
      src="img/staff/lizhijie.png" alt="...">
    </div>

    <!-- TITLE SHORT GOES HERE -->
    <div class="col-md-7">
      <p><div class="detailedheading">简介</div></p>
      <p><b>性别：</b>女</p>
      <p><b>学位：</b>博士</p>
      <p><b>职称：</b>教授，研究员，博士生导师</p>
      <p><b>职务：</b>实验研究中心常务副主任</p>
      <p><b>研究内容: </b>根据对儿童实体瘤（主要是神经母细胞瘤）在临床治疗中产生耐药或转移的现象观察，研究肿瘤耐药或转移产生的机制，确定相关的信号通路（PI3K, MAPK）及信号通路中关键的生物靶分子(AKT, GSK-3β,BIM)，寻找合适的生物靶分子抑制剂（PERIFOSINE, MK-2206），单独或与化疗药物联合使用进行临床前期的实验研究，为生物靶分子抑制剂的临床应用奠定基础。</p>


    </div>
  </div> <!-- END IMAGE INNER ROW -->


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieedu">
      <div class="detailedheading">
        受教育经历
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieedu" class="list-group panel-collapse collapse">

      <div class="list-group-item">1985.9---1990.7: 中国医科大学，儿科系，本科</div>
      <div class="list-group-item">1990.9---1993.7: 中国医科大学，儿科血液与肿瘤学专业，硕士 </div>
      <div class="list-group-item">1997.9---2000.7: 中国医科大学，影像医学与核医学专业，博士 </div>

    </div>
  </div>

  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieworkexp">
      <div class="detailedheading">
        研究工作经历
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieworkexp" class="list-group panel-collapse collapse">

      <div class="list-group-item">1993.7--1995.10：中国医科大学附属盛京医院，住院医师</div>
      <div class="list-group-item">1995.10--2003.2：中国医科大学附属盛京医院，讲师/主治医师</div>
      <div class="list-group-item">2001.2---2002.2：日本庆应大学医学院，访问学者</div>
      <div class="list-group-item">2003.2---2007.5: 美国国立卫生研究院（NIH），国家癌症研究所(NCI)，儿科肿瘤部(POB)，细胞和分子生物学实验室，博士后学者</div>
      <div class="list-group-item">2007.6---2012.6: 美国国立卫生研究院（NIH），国家癌症研究所(NCI)，儿科肿瘤部(POB)，细胞和分子生物学实验室，研究学者</div>
      <div class="list-group-item">2012.10---至今：中国医科大学附属盛京医院，实验研究中心，教授，研究员，</div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijiedir">
      <div class="detailedheading">
        研究方向和内容
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijiedir" class="list-group panel-collapse collapse">

      <div class="list-group-item list-group-item-info">研究方向：</div>
      <div class="list-group-item stafflisttab">肿瘤的耐药机制和生物靶分子治疗</div>
      <div class="list-group-item list-group-item-info">研究内容：</div>
      <div class="list-group-item stafflisttab">根据对儿童实体瘤（主要是神经母细胞瘤）在临床治疗中产生耐药或转移的现象观察，研究肿瘤耐药或转移产生的机制，确定相关的信号通路（PI3K, MAPK）及信号通路中关键的生物靶分子(AKT, GSK-3β,BIM)，寻找合适的生物靶分子抑制剂（PERIFOSINE, MK-2206），单独或与化疗药物联合使用进行临床前期的实验研究，为生物靶分子抑制剂的临床应用奠定基础。</div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijiekeyian">
      <div class="detailedheading">
        <span class="pull-left badge">4</span>科研课题
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijiekeyian" class="list-group panel-collapse collapse">

      <div class="list-group-item list-group-item-info">1.	国家自然科学基金课题-面上项目，项目负责人</div>
      <div class="list-group-item stafflisttab">2013.1-2016.12： AKT 抑制剂PERIFOSINE抑制神经母细胞瘤生长新机制的研究 （课题号：81272538）， 70万元</div>
      <div class="list-group-item list-group-item-info">2.  2013年辽宁省高等学校攀登学者， 150万元</div>
      <div class="list-group-item list-group-item-info">3.  辽宁省科委社发项目， 第二负责人</div>
      <div class="list-group-item stafflisttab">2013.1-2015.12： akt信号通路介导神经母细胞瘤肿瘤转移的研究(课题号： 201225016), 10万元</div>

      <div class="list-group-item list-group-item-info">4.
        国家自然科学基金课题-面上项目，   课题负责人 </div>
 <div class="list-group-item stafflisttab">
   2015.1-2018.12：Akt抑制剂MK-2206和Rapamycin联合应用治疗神经母细胞瘤
   产生协同效应的机制研究 （课题号： 81472359） 72万元
   </div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijiepapers">
      <div class="detailedheading">
        <span class="pull-left badge">17</span> 发表SCI文章
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijiepapers" class="list-group panel-collapse collapse">

      <p>目前共发表SCI文章17篇，总影响因子为101 ；其中第一作者或通讯作者文章10篇，总影响因子为56.6，单篇文章最高影响因子为14.697。<b>*：通讯作者</b></p>

      <div class="list-group-item">1.	Fei Tan, Thiele J Carol, <b><u>Zhijie Li *</b></u>. Collapsin response mediator proteins: potential diagnostic and prognostic biomarkers in cancers (Reviews). Oncol Lett. 2014, 7(5):1333-1340. </div>
      <div class="list-group-item">2.	Fei Tan, Wahdan-Alaswad Reema, Shuang Yan, Carol J Thiele,  <b><u>Zhijie Li *</b></u>.  DPYSL3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci, 2013，104（12）：1586-1592. <span class="label label-primary">SCI IF: 3.479 </span> </div>
      <div class="list-group-item">3.	 <b><u>Zhijie Li *</b></u>，Shuang Yan, Navid Attayan, Sridevi Ramalingam, Carol J. Thiele. Combination of an allosteric Akt inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma. Clinical Cancer Research. 2012,18(13): 3603-3615. <span class="label label-primary">SCI IF: 7.837 </span> </div>
      <div class="list-group-item">4.	 <b><u>Zhijie Li *</b></u>, Doo-Yi Oh, Katsuya Nakamura, Carol J Thiele. Perifosine-induced inhibition of Akt attenuates BDNF/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer, 2011, 117: 5412-5422. <span class="label label-primary">SCI IF: 4.771</span> </div>
      <div class="list-group-item">5.	 <b><u>Zhijie Li </b></u>, Fei Tan, David Liewehr, Seth Steinberg , Carol J. Thiele. In vitro and In vivo Inhibition of Neurblastoma Tumor Cell Growth by AKT Inhibitor Perifosine. The Journal of National Cancer Institute (JNCI), 2010，102（11）：758-770.  <span class="label label-primary">SCI IF: 14.697 </span> </div>
      <div class="list-group-item">6.	 <b><u>Zhijie Li </b></u>, Jinhua Zhang, Zhihui Liu, Chan-Wook Woo, Carol J. Thiele Downregulation of Bim by Brain-derived Neurotrophic Factor/TrkB Protects Neuroblastoma Cells from Paclitaxel but not Etoposide or Cisplatin-induced Cell Death.  Cell Death & Diffferentiation. 2007, 14(2): 318-326. <span class="label label-primary">SCI IF: 8.254 </span> </div>
      <div class="list-group-item">7.	 <b><u>Zhijie Li </b></u>, Fei Tan, Carol Thiele. Inactivation of GSK-3ß contributes to BDNF/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Molecular Cancer Therapeutics. 2007, 6(12pt1): 3113-3121. <span class="label label-primary">SCI IF: 4.8 </span> </div>
      <div class="list-group-item">8.	 <b><u>Zhijie Li </b></u>, Carol J. Thiele. Targeting Akt to increase the sensitivity of Neuroblastoma to chemotherapy: lessons learned from the BDNF/TrkB signal transduction pathway. Experts Opin Ther Targets. 2007, 11(12): 1611-1621. <span class="label label-primary">SCI IF: 3.333</span> </div>
      <div class="list-group-item">9.	 <b><u>Zhijie Li </b></u>, Jerry Jaboin, Phillip A. Dennis and Carol J. Thiele Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.   Cancer Res. 2005, 65(6): 2070-2075. <span class="label label-primary">SCI IF: 7.616 </span> </div>
      <div class="list-group-item">10.	 <b><u>Zhijie Li </b></u>, Hiroshi Matsuda, Takashi Asada, Takashi Ohnishi, Hidekazu Kanetaka, Etsuko Imabayashi, Fumiko Tanaka. Gender difference in brain perfusion 99mTc-ECD SPECT in aged healthy volunteers after correction for partial volume effects. Nucl Med Commun. 2004, 25(10): 999-1005. <span class="label label-primary">SCI IF: 1.602 </span> </div>
      <div class="list-group-item">11.	Shuang Yan,  <b><u>Zhijie Li </b></u>, Carol J Thiele. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and pediatric sarcomas in vitro and in vivo. Oncotarget, 2013, 4(3): 433-445. <span class="label label-primary">SCI IF: 6.636 </span> </div>
      <div class="list-group-item">12.	Carol J. Thiele,  <b><u>Zhijie Li </b></u>, Amy McKee. "On Trk" - the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clinical Cancer Research, 2009 15(19):5962-5967. <span class="label label-primary">SCI IF: 6.747 </span> </div>
      <div class="list-group-item">13.	Jyoti Panicker, <b><u> Zhijie Li </b></u>, Christine McMahon, Caroline Sizer, Kenneth Steadman, Richard Piekarz, Susan E. Bates and Carol J. Thiele. Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells. Cell Cycle. 2010, 9(9):1830-8. <span class="label label-primary">SCI IF: 4.999 </span> </div>
      <div class="list-group-item">14.	Nakamura K, Tan F,  <b><u>Zhijie Li </b></u>, Thiele CJ. NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α. Mol Cell Neurosci. 2011, 46(2):498-506. <span class="label label-primary">SCI IF: 3.663 </span> </div>
      <div class="list-group-item">15.	Liu Z, Yang X,  <b><u>Zhijie Li </b></u>, McMahon C. Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell death and Differentiation. 2011, 18: 1174-1183. <span class="label label-primary">SCI IF: 8.849</span> </div>
      <div class="list-group-item">16.	Wang C, Liu Z, Woo CW,  <b><u>Zhijie Li </b></u>, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, Ge K, Thiele CJ. EZH2 mediates epigenetic silencing of neuroblaastoma suppressor genes CAZZ1, CLU, RUNX3, and NGFR. Cancer Research. 2012, 72:315-324. <span class="label label-primary">SCI IF: 8.65 </span> </div>
      <div class="list-group-item">17.	Matsuda H, Ohnishi T, Asada T,  <b><u>Zhijie Li </b></u>, Kanetaka H, Imabayashi E, Tanaka F, Nakano S.  Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med. 2003, 44(8): 1243-1252. <span class="label label-primary">SCI IF: 4.899</span> </div>


    </div>
  </div>



  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijiechnpapers">
      <div class="detailedheading">
        <span class="pull-left badge">20</span>发表中文文章
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijiechnpapers" class="list-group panel-collapse collapse">

      <div class="list-group-item">1.	<b><u>李志杰</b></u>; 谭斐; 裴著果; 张彩霞。99mTcm-HMPAO在大鼠大脑神经细胞内的分布研究。中华核医学杂志，2001, 21(6):353-355.</div>
      <div class="list-group-item">2.	<b><u>李志杰</b></u>; 谭斐; 裴著果; 张彩霞。局灶性脑缺血后失联络区酶组织化学研究。中华核医学杂志，2001, 21 (5): 273-274.</div>
      <div class="list-group-item">3.	<b><u>李志杰</b></u>; 徐微娜; 裴著果。儿童病毒性脑炎99Tcm-ECD SPECT脑血流显像的研究。中华核医学杂志，2001. 20(3):127-129.</div>
      <div class="list-group-item">4.	<b><u>李志杰</b></u>; 谭斐; 裴著国; 张彩霞。99mTc-HMPAO放射自显影诊断脑梗塞半暗区的实验研究。中国医科大学学报，2000 (S1): 46-49.</div>
      <div class="list-group-item">5.	<b><u>李志杰</b></u>; 刘长平; 张彩霞; 裴著果。婴幼儿99Tcm-MIBI心肌灌注断层显像特点分析。中华核医学杂志，2000,20(1):31-32.</div>
      <div class="list-group-item">6.	<b><u>李志杰</b></u>; 裴著果。脑梗塞缺血半暗区的核医学显像。国外医学(放射医学核医学分册)，1999 23(4):145-149.</div>
      <div class="list-group-item">7.	<b><u>李志杰</b></u>; 裴著果。放射性核素显像在小儿中枢神经系统中的应用。引进国外医药技术与设备，1999, 5(8):53-57.  </div>
      <div class="list-group-item">8.	<b><u>李志杰</b></u>; 裴著果。核医学显像技术在心脏肿瘤中的应用。中国临床医学影像杂志，1998, 9(4):247-249.</div>
      <div class="list-group-item">9.	<b><u>李志杰</b></u>; 裴著果。核医学显像技术在小儿急症中的应用。小儿急救医学，1998, 5(3):104-105.</div>
      <div class="list-group-item">10.	<b><u>李志杰</b></u>; 裴著果. 异位甲状腺合并甲状腺功能减低症一例。临床医学影像杂志,1997, 8(4):301.</div>
      <div class="list-group-item">11.	<b><u>李志杰</b></u>; 张惠; 张锦华. 郎格罕氏细胞组织细胞增生症随访1例。小儿急救医学杂志，1995，2(3):137.</div>
      <div class="list-group-item">12.	<b><u>李志杰</b></u>; 张殿元; 李永田; 张锦华; 张立忠; 骆少敏; 王丽娟。急性白血病患儿血假尿苷测定及临床意义。中华血液学杂志，1995, 16(4):207-208。</div>
      <div class="list-group-item">13.	张彩霞; <b><u>李志杰</b></u>; 徐微娜; 李剑明; 刘长平; 夏雁君; 尹丽。三维立体图像判定肝占位病变性质的意义。中国临床医学影像杂志，2000, 11(1): 20-22。</div>
      <div class="list-group-item">14.	郝良纯; <b><u>李志杰</b></u>; 张立忠; 林丽。Wiskott-Aldrich综合征综合报告及文献复习。中国优生与遗传杂志，1997, 5(5):73-74。</div>
      <div class="list-group-item">15.	郝良纯; <b><u>李志杰</b></u>; 张立忠; 邢芳玉; 杨广洪。儿童Wilson病的心血管变化及其意义。临床儿科杂志，1997, 15(1):41-42.</div>
      <div class="list-group-item">16.	杨丽梅; <b><u>李志杰</b></u>; 徐大庆。先天性急性淋巴细胞白血病2例。小儿急救医学杂志，1995，2(3):137.</div>
      <div class="list-group-item">17.	张彩霞; 张跃祥; 刘长平; <b><u>李志杰</b></u>; 李剑明; 夏雁军; 徐微娜; 裴著果。心钠素和肺灌注显像判定肺动脉高压程度的研究。中国医科大学学报，2001, 30(1):61-63。</div>
      <div class="list-group-item">18.	张彩霞; 徐薇娜; 张耀祥; 李剑明; 于树鹏; <b><u>李志杰</b></u>; 刘长平; 夏雁军。消炎痛与153Sm-EDTMP对骨转移瘤的止痛效果观察。中华核医学杂志，2001, 21(2):117。</div>
      <div class="list-group-item">19.	于宪一; 朴英爱; 韩玉昆; 魏克伦; <b><u>李志杰</b></u>; 裴著果; 张彩霞。潘生丁负荷99mTc-MIBI心肌断层显像诊断川崎病心肌缺血的价值。中华核医学杂志，1998, 18(2):79。</div>
      <div class="list-group-item">20.	刘俊秀; 康玉振; <b><u>李志杰</b></u>; 高宏。1例后天获得性弓形体感染。小儿急救医学杂志，1994，1(1):46.</div>

    </div>
  </div>



  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieintl">
      <div class="detailedheading">
        <span class="pull-left badge">15</span>参加国际会议
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieintl" class="list-group panel-collapse collapse">

      <div class="list-group-item">1.	Fei Tan, Chen Zhao, <b><u>Zhijie Li</u></b>. ERK5 positively regulates HIF-1a activity in neuroblastoma SY5Y cells. ----ANR (Advanced Neuroblastoma Research) meeting in Cologne, Germany, May 13-16, 2014.</div>
      <div class="list-group-item">2.	<b><u>Zhijie Li</u></b>, Shuang Yan, Navid Atteny, Sridevi Ramalingama, Carol J Thiele. Synergistic induction of cell death by ROS using alloseric Akt inhibtor MK-2206 and rapamycin.----ANR (Advanced Neuroblastoma Research) meeting in Toronto, Canada, June 18-21, 2012.</div>
      <div class="list-group-item">3.	<b><u>Zhijie Li</u></b>, Sridevi Ramalingama, Carol J Thiele. The allosteric Akt inhibitor MK-2206 inhibits neuroblastoma tumor cell growth in vitro and in vivo—AACR (American Association for Cancer Research) meeting in Orlando, U.S.A, Apri 2-6, 2011.</div>
      <div class="list-group-item">4.	<b><u>Zhijie Li</u></b>, Carol J Thiele. Irrespective of ALK mutational status, Neuroblastoma tumors are sensitive to Akt inhibitor perifosine. ANR (Advanced Neuroblastoma Research) meeting Stockholm, Sweden, June 21-24, 2010.</div>
      <div class="list-group-item">5.	<b><u>Zhijie Li</u></b>, Carol J Thiele. Neuroblastoma tumors with different ALK mutations are sensitive to Perifosine.----- AACR (American Association for Cancer Research) meeting in Washington DC, U.S.A. April 17-21, 2010,</div>
      <div class="list-group-item">6.	<b><u>Zhijie Li</u></b>, Fei Tan, Jenna Tong, Amy McKee, Carol J.Thiele.  Perifosine, as a single agent, inhibits neuroblastoma tumor cell growth in in vitro and in vivo preclinical models------ AACR (American Association for Cancer Research) meeting in Denver, U.S.A. April 18-22, 2009. </div>
      <div class="list-group-item">7.	<b><u>Zhijie Li</u></b>, Amy McKee, Carol J. Thiele. Perifosine, an Akt inhibitor, sensitizes Neuroblastoma to etoposide treatment. ANR(Advanced Neuroblastoma Research) meeting in Chiba, Japan, May 21-24, 2008. </div>
      <div class="list-group-item">8.	<b><u>Zhijie Li</u></b>, Carol J. Thiele. Neurotrophic receptor TrkB: A predictor of chemo-resistance in neuroblastoma. ---AACR (American Association for Cancer Research) meeting in San Diego, California, U.S.A. April 12-16, 2008. </div>
      <div class="list-group-item">9.	<b><u>Zhijie Li</u></b>. Neurotrophic receptor TrkB: A predictor of chemo-resistance and metastasis in neuroblastoma. 20th NIH Research Festival. Bethesda U.S.A, September 25-28, 2007.</div>
      <div class="list-group-item">10.	<b><u>Zhijie Li</u></b>, Fei Tan, Jerry Jaboin, Carol J. Thiele. Glycogen synthase kinase-3beta contributes to BDNF/TrkB protection of neuroblastoma cells from chemotherapy-induced cell death. ---AACR (American Association for Cancer Research) meeting in Los Angeles, California, U.S.A.  April 14-18, 2007. </div>
      <div class="list-group-item">11.	<b><u>Zhijie Li</u></b>, Jinhua Zhang, Zhihui Liu, Carol J. Thiele. Phosphorylation and inactivation of GSK-3 by BDNF/TrkB protects neuroblastoma cells from chemotherapy-induced cell death.---ANR (Advanced Neuroblastoma Research) meeting in Los Angeles, California, U.S.A. May 17-20, 2006. </div>
      <div class="list-group-item">12.	<b><u>Zhijie Li</u></b>, Carol J. Thiele. Downregulation of Bim by BDNF/TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. ---AACR (American Association for Cancer Reaearch) meeting in Washington D, C. U.S.A. April 1-5, 2006.</div>
      <div class="list-group-item">13.	<b><u>Zhijie Li</u></b>, Jerry Jaboin, Phillip A. Dennis, Carol J. Thiele. Genetic and pharmacologic identification of Akt as a mediator of BDNF/TrkB rescue of SY5Y neuroblastoma cells from etoposide-induced cell death. ---AACR (American Association for Cancer Research) meeting in Anaheim, California, U.S.A.  April 16-20, 2005. </div>
      <div class="list-group-item">14.	<b><u>Zhijie Li</u></b>, Jerry Jaboin, Carol J.Thiele. Akt pathway mediates BDNF/TrkB resistance to chemotherapy in neuroblastoma cells. ANR (Advances in Neuroblastoma Research) in Genova, Italy. June 16-19, 2004. </div>
      <div class="list-group-item">15.	<b><u>Zhijie Li</u></b>, Kayoko Nakamura, Hirofumi Fujii, Atsushi Kubo. Assessment of anti-p-glycoprotein monoclonal antibody as MDR-modifier by using Tc-99m-MIBI.--- 41ST Annual Meeting of the Japanese Society of Nuclear Medicine, Kanazawa, Japan. October 17-19, 2001. </div>



    </div>
  </div>





  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieawards">
      <div class="detailedheading">
        <span class="pull-left badge">5</span>科研奖励
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieawards" class="list-group panel-collapse collapse">

      <div class="list-group-item">1.	2001年: 亚洲和太平洋地区杰出青年研究者奖，第41届日本核医学年会，日本 （Asia and Oceania Distinguished Young Investigator’s Award in 41ST Annual Meeting of the Japanese Society of Nuclear Medicine, Japan）。</div>
      <div class="list-group-item">2.	2005年: NIH优秀研究奖，美国国立卫生研究院，美国（Fellows Award for Research Excellence in NIH, U.S.A）。</div>
      <div class="list-group-item">3.	2006年: 优秀组织者奖，美国国立卫生研究院，美国（“Merit award” in NIH, U.S.A）</div>
      <div class="list-group-item">4.	2008年: NIH优秀研究奖，美国国立卫生研究院，美国（Fellows Award for Research Excellence in NIH, U.S.A）</div>
      <div class="list-group-item">5. 2013年：中国医科大学附属盛京医院 “优秀中标课题”奖。</div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijiedouble">
      <div class="detailedheading">
        <span class="pull-left badge">3</span>学术兼职
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijiedouble" class="list-group panel-collapse collapse">

      <div class="list-group-item">2001-2003：中华医学会核医学分会，中青年委员</div>
      <div class="list-group-item">2001-2003：沈阳医学会核医学分会，委员会委员</div>
      <div class="list-group-item">2013-至今：中国小儿血液与肿瘤杂志，编委</div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieworks">
      <div class="detailedheading">
        <span class="pull-left badge">4</span>参加编写教材或著作
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieworks" class="list-group panel-collapse collapse">

      <div class="list-group-item list-group-item-info">1. <b><u>著作：Neurotoxicity handbook</u></b></div>
      <div class="stafflisttab">
        <div class="list-group-item">出版日期：2014年</div>
        <div class="list-group-item">出版社： Springer Science+Business Media New York</div>
        <div class="list-group-item">主要工作：参与其中一章Neurotrophin Signaling in Cancer的编写</div>
      </div>

      <div class="list-group-item list-group-item-info">2. <b><u>著作：神经母细胞瘤</u></b></div>
      <div class="stafflisttab">
        <div class="list-group-item">出版日期：2009年9月</div>
        <div class="list-group-item">出版社：人民卫生出版社</div>
        <div class="list-group-item">主要工作：负责书中第七章部分的编写</div>
      </div>

      <div class="list-group-item list-group-item-info">3. <b><u>教材：影像核医学（第三版）</u></b></div>
      <div class="stafflisttab">
        <div class="list-group-item">出版日期：2007年8月</div>
        <div class="list-group-item">出版社：人民卫生出版社</div>
        <div class="list-group-item">主要工作：副主编，负责第19章的编写</div>
      </div>

      <div class="list-group-item list-group-item-info">4. <b><u>教材：影像核医学（第二版）</u></b></div>
      <div class="stafflisttab">
        <div class="list-group-item">出版日期： 2005年5月</div>
        <div class="list-group-item">出版社：人民卫生出版社</div>
        <div class="list-group-item">主要工作：负责第18章编写。</div>
      </div>

    </div>
  </div>


  <!-- ALL DETAILS GOES HERE -->
  <div class="detaileddescription">
    <!-- remember to change HREF -->
    <p><a data-toggle="collapse" href="#lizhijieemail">
      <div class="detailedheading">
        联系方式
    </div></a></p>

    <!-- REMEMBER to change HREF -->
    <div id= "lizhijieemail" class="list-group panel-collapse collapse">

      <div class="list-group-item">E-Mail: lizj@sj-hospital.org</div>

    </div>
  </div>


</div> <!-- END MODAL BODY -->
<div class="modal-footer">
  <button type="button" class="btn btn-default"
    data-dismiss="modal">关闭</button>
</div>




